HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Boosting the Alkali/Heavy Metal Poisoning Resistance for NO Removal by Using Iron-Titanium Pillared Montmorillonite Catalysts.

Abstract
It is still a big challge to improve the alkali and heavy metal resistance of deNOx catalysts for selective catalytic reduction (SCR) of NOx with NH3. In this study, a novel catalyst developed by pillaring montmorillonite with iron and titanium (Fe-Ti-MMT) was proposed. It is quite interesting that high resistance to alkaline and heavy metals has been demonstrated by using Fe-Ti-MMT catalysts. It has been demonstrated that the specific pillaring synthesis procedure and further addition of the Ti pillared sites greatly contributed to the wide active temperature window and enhanced the resistance to alkali and heavy metal. The higher ratio of active Fe2+ species, more active acid sites, and enhanced ammonia adsorption indicated the remarkable activity as well as K and Pb resistance. Moreover, the K and Pb poisons would promote the generation of active adsorbed NOx species on the Fe-Ti-MMT but induce the formation of stable inactive ones on that of Fe-MMT, which greatly tuned the reaction pathways and improved the reaction rate for Ti modified Fe pillared MMT catalysts. The strategy of incorporating Ti into the Fe pillared MMT catalysts strongly provides a novel inspiration for keeping excellent NH3-SCR performance in the presence of alkali/heavy metal for NOx removal.
AuthorsDong Xu, Wenhao Wu, Penglu Wang, Jiang Deng, Tingting Yan, Dengsong Zhang
JournalJournal of hazardous materials (J Hazard Mater) Vol. 399 Pg. 122947 (11 15 2020) ISSN: 1873-3336 [Electronic] Netherlands
PMID32521318 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2020 Elsevier B.V. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: